Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print June 20, 2007, 10.1148/radiol.2442060713
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Appendix E1
Right arrow All Versions of this Article:
2442060713v1
244/2/505    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Helvoort-Postulart, D.
Right arrow Articles by Hunink, M. G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Helvoort-Postulart, D.
Right arrow Articles by Hunink, M. G. M.
(Radiology 2007;244:505-513.)
© RSNA, 2007


Health Policy and Practice

Renal Artery Stenosis: Cost-effectiveness of Diagnosis and Treatment1

Debby van Helvoort-Postulart, PhD, Carmen D. Dirksen, PhD, Patricia J. Nelemans, MD, PhD, Abraham A. Kroon, MD, PhD, Alfons G. H. Kessels, MD, Peter W. de Leeuw, MD, PhD, G. Boudewijn C. Vasbinder, MD, PhD, Jos M. A. van Engelshoven, MD, PhD, and M. G. Myriam Hunink, MD, PhD

1 From the Departments of Clinical Epidemiology and Medical Technology Assessment (D.v.H., C.D.D., A.G.H.K.), Internal Medicine (A.A.K., P.W.d.L.), and Radiology (G.B.C.V., J.M.A.v.E.), University Hospital Maastricht, P Debyelaan 25, 6229 HX Maastricht, the Netherlands; Department of Epidemiology, University of Maastricht, Maastricht, the Netherlands (P.J.N.); Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands (A.A.K., P.W.d.L., J.M.A.v.E.); Departments of Epidemiology and Biostatistics, and Radiology, Erasmus Medical Center, Rotterdam, the Netherlands (M.G.M.H.); and Department of Health Policy and Management, Harvard School of Public Health, Boston, Mass (M.G.M.H.). Received April 24, 2006; revision requested June 23; revision received September 11; accepted October 12; final version accepted December 4. Supported by the Dutch Health Care Insurance Board (grant OG 97-003). Address correspondence to D.v.H. (e-mail: debby.van.helvoort{at}home.nl).

Purpose: To use a decision analytic model to determine the cost-effectiveness of performing diagnostic digital subtraction angiography (DSA), computed tomographic (CT) angiography, or magnetic resonance (MR) angiography or proceeding immediately to tentative percutaneous revascularization in patients suspected of having renovascular hypertension.

Materials and Methods: With use of a Markov–Monte Carlo decision model, cost-effectiveness analysis was performed from a societal perspective. Data were derived from the Renal Artery Diagnostic Imaging Study in Hypertension and from published literature. The base-case analyses were used to evaluate a 50-year-old patient with a diastolic blood pressure higher than 95 mm Hg and one or more clinical clues suggestive of renovascular hypertension. Outcome measures were quality-adjusted life-year (QALY), lifetime costs, and incremental cost-effectiveness.

Results: For a 50-year-old male patient, immediate tentative revascularization was the least costly ({euro}54 415) and most effective (12.265 QALYs) strategy. For the other strategies, costs and QALYs, respectively, were {euro}55 570 and 12.195 for DSA, {euro}55 191 and 12.163 for CT angiography, and {euro}56 890 and 12.088 for MR angiography. For a 50-year-old female patient, costs and QALYs, respectively, were {euro}66 731 and 13.731 for MR angiography, {euro}63 970 and 13.749 for CT angiography, and {euro}63 079 and 13.902 for DSA. Immediate tentative revascularization yielded more QALYs (13.937) and was more costly ({euro}63 329) than DSA. The incremental cost-effectiveness ratio was {euro}7143 per QALY. As the prior probability increased, use of a more invasive diagnostic imaging strategy became justified. Also, the sensitivities of CT angiography and MR angiography and the costs of DSA influenced the results.

Conclusion: Given currently accepted incremental cost-effectiveness ratios, immediate tentative percutaneous revascularization is a cost-effective strategy for the diagnosis of renal artery stenosis. Management decisions should be conditional on the prior probability.

Supplemental material: http://radiology.rsnajnls.org/cgi/content/full/2442060713/DC1

© RSNA, 2007







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2007 by the Radiological Society of North America.